Unveiling Ovarian Toxicity: Beyond Fertility in Cancer Care
05/08/24 • 28 min
Welcome to the latest episode of Supportive Care Matters. Join Medical Oncologist Professor Bogda Koczwara AM and Dr. Wanda Cui as they dive deep into the often overlooked complexities of ovarian toxicity in cancer care.
In this engaging conversation, Bogda and Wanda go beyond the surface discussions of fertility to explore the vital importance of a woman's overall ovarian health after cancer treatment. They discuss the far-reaching effects of early menopause triggered by cancer therapies on cardiovascular and bone health, shedding light on the significance of safeguarding reproductive potential through fertility preservation methods.
Together, they tackle the challenges of measuring ovarian function in clinical practice, highlighting the disparities in menstrual recovery among different age groups post-treatment. By exploring predictive values and the effectiveness of indicators like menstruation, pregnancy rates, and hormonal levels, they provide insights into personalised clinical practices essential for addressing individual patient needs.
The discussion also emphasises the urgent need for improved research in ovarian toxicity, particularly within breast cancer trials where data is lacking. Supportive Care Matters isn't just a podcast; it's a call to action for greater patient involvement and policy change in cancer care.
Join us as we navigate the complexities of ovarian toxicity and strive for better support and care for cancer patients everywhere. Visit www.oncologynews.com.au for show notes and more information about Supportive Care Matters!
This conversation is proudly produced by The Oncology Network.
TO VIEW SHOW NOTES AND MORE INFORMATION ABOUT SUPPORTIVE CARE MATTERS, HEAD TO WWW.ONCOLOGYNEWS.COM.AU
Welcome to the latest episode of Supportive Care Matters. Join Medical Oncologist Professor Bogda Koczwara AM and Dr. Wanda Cui as they dive deep into the often overlooked complexities of ovarian toxicity in cancer care.
In this engaging conversation, Bogda and Wanda go beyond the surface discussions of fertility to explore the vital importance of a woman's overall ovarian health after cancer treatment. They discuss the far-reaching effects of early menopause triggered by cancer therapies on cardiovascular and bone health, shedding light on the significance of safeguarding reproductive potential through fertility preservation methods.
Together, they tackle the challenges of measuring ovarian function in clinical practice, highlighting the disparities in menstrual recovery among different age groups post-treatment. By exploring predictive values and the effectiveness of indicators like menstruation, pregnancy rates, and hormonal levels, they provide insights into personalised clinical practices essential for addressing individual patient needs.
The discussion also emphasises the urgent need for improved research in ovarian toxicity, particularly within breast cancer trials where data is lacking. Supportive Care Matters isn't just a podcast; it's a call to action for greater patient involvement and policy change in cancer care.
Join us as we navigate the complexities of ovarian toxicity and strive for better support and care for cancer patients everywhere. Visit www.oncologynews.com.au for show notes and more information about Supportive Care Matters!
This conversation is proudly produced by The Oncology Network.
TO VIEW SHOW NOTES AND MORE INFORMATION ABOUT SUPPORTIVE CARE MATTERS, HEAD TO WWW.ONCOLOGYNEWS.COM.AU
Previous Episode
The OJC Episode 4: New Zealand vs Australia, Optimising Breast Cancer Treatment, ChatGPT Insights, ASCO Guidelines, Hand-Foot Syndrome and More!
How do cancer outcomes in New Zealand compare to Australia? How can we optimise post-neoadjuvant treatment in patients with early breast cancer who achieve pathologic complete response? Does bevacizumab improve efficacy when administered with platinum combination therapy and atezolizumab in patients with advanced nonsquamous non small cell lung cancer? And how do AI chatbots perform when asked for cancer treatment recommendations?
Welcome to The Oncology Journal Club Podcast – your go-to source for in-depth discussions on the latest oncology research tailored for medical professionals.
Join our esteemed Hosts, Professor Craig Underhill, Dr. Kate Clarke and Professor Christopher Jackson for the low down on the latest oncology papers.
They also discuss ASCO guidelines, inequities, financial conflicts and environmental issues.
But that's not all – we also add a touch of whimsy to the episode, rounding off with a fun song inspired by Craig's latest half marathon, crafted in the style of Taylor Swift (courtesy of CJ's favourite new lyric-writing machine, Chat GPT!).
Tune in to The Oncology Journal Club Podcast for an informative and entertaining journey through the world of oncology research and practice.
For papers, bios and other links visit the Show Notes on our website.For the latest oncology news visit www.oncologynews.com.au.
We invite healthcare professionals to join The Oncology Network for free - you'll also receive our free weekly publication The Oncology Newsletter.
The Oncology Podcast - An Australian Oncology Perspective
Next Episode
Episode 5: Prostate Cancer Treatment + Alcohol + Adjuvant Pembro + Quick Bites
Join us on this episode of The Oncology Journal Club Podcast as we dissect the latest research that point to new standards of care.
Join our esteemed Hosts, Professor Craig Underhill, Dr. Kate Clarke and Professor Christopher Jackson for the low down on the latest oncology papers.
Craig looks at how three-agent regimens have revolutionised the treatment of metastatic hormone-sensitive prostate cancer. Kate asks how alcohol affects lethal prostate cancer risk. And CJ explores the promising results of adjuvant pembrolizumab in resected renal cell carcinoma with his typical in-depth, high-speed and highly nuanced analysis.
Then we shift gears to our popular Quick Bites section (and yes, CJ is at the crackers again!). We look at the halted KeyVibe Adjuvant Melanoma Study, a Chinese trial on oesophageal squamous cell carcinoma, a small trial on dual tyrosine kinase inhibitors for BRAF mutant stage 3 melanoma, the TOPAS1 trial on divalimab in advanced biliary tract cancer and rural clinical trial enrolment.
As always, The OJC team provide a robust analysis of the latest findings in oncology research. Tune in for a comprehensive, insightful and entertaining review of cutting-edge oncology developments.
For papers, bios and other links visit the Show Notes on our website.For the latest oncology news visit www.oncologynews.com.au.
We invite healthcare professionals to join The Oncology Network for free - you'll also receive our free weekly publication The Oncology Newsletter.
The Oncology Podcast - An Australian Oncology Perspective
The Oncology Podcast - Unveiling Ovarian Toxicity: Beyond Fertility in Cancer Care
Transcript
Cancer diagnosis and treatment pose a threat to many aspects of patients' life . For young patients , one of the most distressing is the threat of their reproductive potential in future parenthood . To address this , researchers and clinicians need to understand the risk and measure the impact of cancer treatment on fertility and ovarian toxicity . How can that be done better ? I'
If you like this episode you’ll love
Episode Comments
Generate a badge
Get a badge for your website that links back to this episode
<a href="https://goodpods.com/podcasts/the-oncology-podcast-195049/unveiling-ovarian-toxicity-beyond-fertility-in-cancer-care-51117833"> <img src="https://storage.googleapis.com/goodpods-images-bucket/badges/generic-badge-1.svg" alt="listen to unveiling ovarian toxicity: beyond fertility in cancer care on goodpods" style="width: 225px" /> </a>
Copy